H1N1 Virus

Clinical trial pipeline · Data from ClinicalTrials.gov

See which H1N1 Virus trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07215858

BPL-1357 Against H1N1 Influenza Virus Challenge

Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it…

United States129 participantsStarted 2026-06-23

Treatment: BPL-1357 IM, BPL-1357 IN

All recent trials (100 shown)

Active — Not RecruitingPhase 3

NCT06087640

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a No…

This Phase 3 study is a randomized, observer-blind study of MF59-adjuvanted influenza vaccine (aQIV or aTIV) compared with a non-adjuvanted influenza vaccine (Q…

United States35,800 participantsStarted 2023-10-23

Treatment: aQIV or aTIV, QIV or TIV

CompletedNot Applicable

NCT01191853

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunizati…

Background: \- Seasonal influenza is a major health problem whose impact is typically reduced by vaccination. The H1N1 (swine flu) influenza virus is an emergi…

United States203 participantsStarted 2009-09-18

H1N1 Virus

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

BPL-1357 Against H1N1 Influenza Virus Challenge

All recent trials (100 shown)

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a No…

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunizati…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

BPL-1357 Against H1N1 Influenza Virus Challenge

All recent trials (100 shown)

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a No…

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunizati…

Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvante…

Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women

"COhort Study on A/H1N1 FLU During PREGnancy"

Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage

Vaccination Against Influenza in Autoimmune Diseases

Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study

Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus…

Study of SAB-176 in Healthy Adult Participants

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

Intramuscular CodaVax-H1N1 in Healthy Adults

Mechanisms of Severe Acute Influenza Consortium (MOSAIC)

A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus

Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine